CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China

China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed ...
Just Baseball

The Pros and Cons of a Rangers Trade of Corey Seager

Corey Seager is one of the newest names to be added to this offseason's trade rumor mill. We look at the pros and cons of him ...